Xenon Pharmaceuticals Inc (XENE) — Free Cash Flow Generation Index

Latest as of December 2019: 0.97x

Xenon Pharmaceuticals Inc (XENE) has a Free Cash Flow Generation Index of 0.97x as of December 2019. Free cash flow of $19.14 Million represents 1% of operating cash flow ($19.73 Million). See how liquid is Xenon Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.97x
Free Cash Flow / Operating CF

Free Cash Flow

$19.14 Million
USD

Operating Cash Flow

$19.73 Million
USD

Capital Expenditures

$595.00K
USD

Xenon Pharmaceuticals Inc Free Cash Flow Generation Index (2012–2014)

Historical FCF Generation Index trend for Xenon Pharmaceuticals Inc across 2 annual periods. Explore Xenon Pharmaceuticals Inc (XENE) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Xenon Pharmaceuticals Inc (2012–2014)

Year-by-year Free Cash Flow Generation Index for Xenon Pharmaceuticals Inc. For the full company profile including market capitalisation, see XENE market cap.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2014 -4.75x $-1.26 Million $266.00K $1.53 Million ▼ -580.4%
2012 0.99x $45.05 Million $45.57 Million $526.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).